Linklaters has advised nexfibre and its investors, InfraVia, Liberty Global and Telefónica. Proskauer has advised the lenders of nexfibre. Freeths has advised the Substantial Group. Nexfibre,...
Nexfibre Joint Venture Acquires Substantial Group for £2 Billion
BioNTech to Acquire CureVac in US$1.25 Billion All-Stock Transaction
Skadden and NautaDutilh N.V. have advised CureVac. Covington & Burling LLP, Hengeler Mueller Partnerschaft von Rechtsanwälten mbB and Loyens & Loeff N.V. have advised BioNTech. BioNTech...
Getinge’s $477 Million Acquisition of Paragonix Technologies
Covington & Burling represented Getinge in the transaction. Getinge announced its acquisition of Paragonix Technologies, Inc., a leading organ transport products and services company in the...
AstraZeneca’s Acquisition of CinCor Pharma
Covington & Burling advised AstraZeneca. Skadden represented Centerview Partners LLC, the exclusive financial advisor to CinCor Pharma Inc. Cooley advised CinCor Pharma. CinCor Pharma Inc. (“CinCor”)...
Indivior’s $145 Million Acquisition of Opiant Pharmaceuticals
Covington & Burling LLP advised Indivior, while Latham & Watkins LLP represented Opiant in the transaction. Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) has entered into a definitive...
UCB’s Acquisition of Zogenix
Covington represented UCB, while Latham & Watkins represented Zogenix on the deal. Fried Frank acted as counsel to BofA Securities and SVB Leerink as financial advisors to...